Waldman Reid Alexander
Chief Executive Officer
Waldman Reid Alexander has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
On the most recent filing, Waldman Reid Alexander is listed as Chief Executive Officer at Veradermics, Inc. Inside the rolling window, Waldman Reid Alexander reported no open-market purchases and 1 open-market sale totaling $7.3M in MANE.
Companies traded
Other insiders at MANE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Waldman Reid Alexander made?
Waldman Reid Alexander has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Waldman Reid Alexander trade?
Waldman Reid Alexander has filed SEC Form 4 disclosures for 1 company, including MANE.
When was Waldman Reid Alexander's most recent SEC Form 4 filing?
Waldman Reid Alexander's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.
What is Waldman Reid Alexander's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Waldman Reid Alexander is listed as Chief Executive Officer.
What is Waldman Reid Alexander's total buy and sell value in the current window?
Inside the rolling retention window, Waldman Reid Alexander bought $0 and sold $7.3M based on SEC Form 4 filings.
What was Waldman Reid Alexander's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 67,500 MANE shares on 2026-08-17, worth $7.3M, per SEC Form 4 filings.